You just read:

Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Huntington's Disease

News provided by

Ionis Pharmaceuticals, Inc.

Dec 11, 2017, 07:00 ET